OMEICOS Therapeutics
PrivateLast Round
Grant
Jun 21, 2023
Total Funding Raised
$42.26M
Company Overview
OMEICOS Therapeutics is a biopharmaceutical company that develops first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular, ophthalmic, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OMEICOS Therapeutics Comparables
Compare OMEICOS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Khondrion | 86% | |
| Abliva AB (publ) | 80% | |
| Reneo Pharmaceuticals | 78% | |
OMEICOS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 21, 2023 | ||||
| Series C | Nov 2, 2018 | ||||
| Series B Extension | Oct 4, 2017 | ||||
| Grant | Jun 7, 2017 | ||||
| Series B | Mar 1, 2017 | ||||
Series A | Apr 15, 2015 |
Key People
Founding team and executive leadership
OMEICOS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Ministry of Education and Research | Grant |
| Forbion | Series C |
| IBB Ventures | Series B Extension, Series B, Series A, Seed, Series C |
| Bundesministerium für Bildung und Forschung | Grant |
| Remiges Ventures | Series B, Series C, Series B Extension |
| Ascenion | Series B, Grant |
| Vesalius Biocapital Partners | Series B Extension, Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2026
Grew 80% QoQ from 5 to 9 employees.
- Jun 21, 2023
Received $3M from Bundesministerium für Bildung und Forschung.
OMEICOS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OMEICOS Therapeutics's valuation, stock price, and market status.